↓ Skip to main content

Dove Medical Press

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

Overview of attention for article published in Drug Design, Development and Therapy, January 2021
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
16 Mendeley
Title
A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
Published in
Drug Design, Development and Therapy, January 2021
DOI 10.2147/dddt.s286529
Pubmed ID
Authors

Qingli Cui, Yanhui Hu, Dongyang Ma, Huaimin Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Student > Doctoral Student 3 19%
Student > Postgraduate 2 13%
Other 1 6%
Unknown 10 63%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 6%
Psychology 1 6%
Materials Science 1 6%
Medicine and Dentistry 1 6%
Unknown 12 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2021.
All research outputs
#20,669,432
of 25,387,668 outputs
Outputs from Drug Design, Development and Therapy
#1,437
of 2,269 outputs
Outputs of similar age
#395,543
of 519,506 outputs
Outputs of similar age from Drug Design, Development and Therapy
#20
of 41 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,269 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 22nd percentile – i.e., 22% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,506 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.